![Stuart Lutzker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 5 M $ al 30/06/2026
Stuart Lutzker is the founder of Arrivent BioPharma, Inc., founded in 2021, holding the titles of Director and President-Research & Development since 2022.
Former job includes VP, Head-Oncology & Early Clinical Development at Genentech, Inc. from 2004 to 2021.
Education includes undergraduate studies at The Trustees of Columbia University in The City of New York and a doctorate from Columbia University College of Physicians & Surgeons.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ARRIVENT BIOPHARMA, INC. 0,32 % | 21/04/2026 | 147.744 ( 0,32 % ) | 5 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ARRIVENT BIOPHARMA, INC. | Fundador | 14/04/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/03/2021 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia University College of Physicians & Surgeons
 Columbia University College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arrivent BioPharma, Inc.
 Arrivent BioPharma, Inc. Pharmaceuticals: OtherHealth Technology Engages in development and commercialization of cancer medicines | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
